WEST PHARMACEUTICAL SERVICES, INC. Finance Lease, Right-of-Use Asset, Amortization
WEST PHARMACEUTICAL SERVICES, INC. (WST) reported Finance Lease, Right-of-Use Asset, Amortization of $500.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:FinanceLeaseRightOfUseAssetAmortization · last filed 2026-07-23
- WEST PHARMACEUTICAL SERVICES, INC. finance lease, right-of-use asset, amortization for the quarter ending 2026-06-30 was $500.00K, a 25.00% increase year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. finance lease, right-of-use asset, amortization for the quarter ending 2026-03-31 was $500.00K, a 66.67% increase year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. finance lease, right-of-use asset, amortization for the quarter ending 2025-12-31 was $400.00K, a 33.33% increase year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. finance lease, right-of-use asset, amortization for the quarter ending 2025-09-30 was $500.00K, a 66.67% increase year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. finance lease, right-of-use asset, amortization for fiscal 2025 was $1.60M, a 77.78% increase from fiscal 2024.
- WEST PHARMACEUTICAL SERVICES, INC. finance lease, right-of-use asset, amortization for fiscal 2024 was $900.00K.
- WEST PHARMACEUTICAL SERVICES, INC. finance lease, right-of-use asset, amortization for fiscal 2023 was $0.00.
- WEST PHARMACEUTICAL SERVICES, INC. finance lease, right-of-use asset, amortization for fiscal 2022 was $0.00.
| Period end | Finance Lease, Right-of-Use Asset, Amortization 3 month | Finance Lease, Right-of-Use Asset, Amortization 6 month | Finance Lease, Right-of-Use Asset, Amortization 9 month | Finance Lease, Right-of-Use Asset, Amortization 12 month |
|---|---|---|---|---|
| 2026-06-30 | $500.00K 10-Q · filed 2026-07-23 | $1.00M 10-Q · filed 2026-07-23 | $1.40M derived: sum of 3 quarters · filed 2026-07-23 | $1.90M derived: sum of 4 quarters · filed 2026-07-23 |
| 2026-03-31 | $500.00K 10-Q · filed 2026-04-23 | $900.00K derived: sum of 2 quarters · filed 2026-04-23 | $1.40M derived: sum of 3 quarters · filed 2026-04-23 | $1.80M derived: sum of 4 quarters · filed 2026-07-23 |
| 2025-12-31 | $400.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $900.00K derived: sum of 2 quarters · filed 2026-02-17 | $1.30M derived: sum of 3 quarters · filed 2026-07-23 | $1.60M 10-K · filed 2026-02-17 |
| 2025-09-30 | $500.00K 10-Q · filed 2025-10-23 | $900.00K derived: sum of 2 quarters · filed 2026-07-23 | $1.20M 10-Q · filed 2025-10-23 | $1.50M derived: sum of 4 quarters · filed 2026-07-23 |
| 2025-06-30 | $400.00K 10-Q · filed 2026-07-23 | $700.00K 10-Q · filed 2026-07-23 | $1.00M derived: sum of 3 quarters · filed 2026-07-23 | $1.30M derived: sum of 4 quarters · filed 2026-07-23 |
| 2025-03-31 | $300.00K 10-Q · filed 2026-04-23 | $600.00K derived: sum of 2 quarters · filed 2026-04-23 | $900.00K derived: sum of 3 quarters · filed 2026-04-23 | $1.20M derived: sum of 4 quarters · filed 2026-04-23 |
| 2024-12-31 | $300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $600.00K derived: sum of 2 quarters · filed 2026-02-17 | $900.00K derived: sum of 3 quarters · filed 2026-02-17 | $900.00K 10-K · filed 2026-02-17 |
| 2024-09-30 | $300.00K 10-Q · filed 2025-10-23 | $600.00K derived: sum of 2 quarters · filed 2025-10-23 | $600.00K 10-Q · filed 2025-10-23 | $600.00K derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-06-30 | $300.00K 10-Q · filed 2025-07-24 | $300.00K 10-Q · filed 2025-07-24 | $300.00K derived: sum of 3 quarters · filed 2026-02-17 | $300.00K derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-03-31 | $0.00 10-Q · filed 2025-04-24 | $0.00 derived: sum of 2 quarters · filed 2026-02-17 | $0.00 derived: sum of 3 quarters · filed 2026-02-17 | $0.00 derived: sum of 4 quarters · filed 2026-02-17 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $0.00 derived: sum of 2 quarters · filed 2026-02-17 | $0.00 derived: sum of 3 quarters · filed 2026-02-17 | $0.00 10-K · filed 2026-02-17 |
| 2023-09-30 | $0.00 10-Q · filed 2024-10-24 | $0.00 derived: sum of 2 quarters · filed 2024-10-24 | $0.00 10-Q · filed 2024-10-24 | |
| 2023-06-30 | $0.00 10-Q · filed 2024-07-25 | $0.00 10-Q · filed 2024-07-25 | ||
| 2022-12-31 | $0.00 10-K · filed 2025-02-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |